Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)

ClinicalTrials.gov ID: NCT02414854

Public ClinicalTrials.gov record NCT02414854. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 10:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Persistent Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Primary Objective: To evaluate the efficacy of dupilumab (SAR231893 / REGN668) in participants with persistent asthma. Secondary Objectives: * To evaluate the safety and tolerability of dupilumab. * To evaluate the effect of dupilumab on improving participant-reported outcomes including health-related quality of life. * To evaluate dupilumab systemic exposure and incidence of anti-drug antibodies.

Study identification

NCT ID
NCT02414854
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi
Industry
Enrollment
1,902 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 27, 2015 (Type not available)
Primary completion
Jul 29, 2017 (Actual)
Completion
Nov 23, 2017 (Actual)
Last update posted
Oct 23, 2018

2015 – 2017

United States locations

U.S. sites
116
U.S. states
33
U.S. cities
103
Facility City State ZIP Site status
Investigational Site Number 840047 Birmingham Alabama 35209 —
Investigational Site Number 840056 Flagstaff Arizona 86001 —
Investigational Site Number 840099 Gilbert Arizona 85234 —
Investigational Site Number 840087 Scottsdale Arizona 85251 —
Investigational Site Number 840132 Little Rock Arkansas 72209 —
Investigational Site Number 840109 Bakersfield California 93301 —
Investigational Site Number 840052 Costa Mesa California 92626 —
Investigational Site Number 840116 Fresno California 93720 —
Investigational Site Number 840045 Long Beach California 90720 —
Investigational Site Number 840011 Los Angeles California 90025 —
Investigational Site Number 840061 Los Angeles California 90048 —
Investigational Site Number 840097 Los Angeles California 90064 —
Investigational Site Number 840019 Mission Viejo California 92691 —
Investigational Site Number 840125 Newport Beach California 92663 —
Investigational Site Number 840041 North Hollywood California 91606 —
Investigational Site Number 840036 Redwood City California 94063 —
Investigational Site Number 840020 Rolling Hills Estates California 90274 —
Investigational Site Number 840074 Roseville California 95661 —
Investigational Site Number 840021 San Jose California 95117 —
Investigational Site Number 840004 Centennial Colorado 80112 —
Investigational Site Number 840025 Colorado Springs Colorado 80907 —
Investigational Site Number 840034 Denver Colorado 80230 —
Investigational Site Number 840130 Denver Colorado 80246 —
Investigational Site Number 840102 New Haven Connecticut 06504 —
Investigational Site Number 840037 Aventura Florida 33180 —
Investigational Site Number 840018 Boynton Beach Florida 33472 —
Investigational Site Number 840105 Brandon Florida 33511 —
Investigational Site Number 840092 Clearwater Florida 33765 —
Investigational Site Number 840122 Hialeah Florida 33012 —
Investigational Site Number 840053 Loxahatchee Groves Florida 33470 —
Investigational Site Number 840069 Miami Florida 33173 —
Investigational Site Number 840123 Ocala Florida 34471 —
Investigational Site Number 840071 Ocala Florida 34474 —
Investigational Site Number 840115 Ocoee Florida 34761 —
Investigational Site Number 840055 Sarasota Florida 34239 —
Investigational Site Number 840114 South Miami Florida 33143 —
Investigational Site Number 840048 Tampa Florida 33612 —
Investigational Site Number 840084 Gainesville Georgia 30506 —
Investigational Site Number 840044 Savannah Georgia 31406 —
Investigational Site Number 840079 Twin Falls Idaho 83301 —
Investigational Site Number 840101 Chicago Illinois 60611 —
Investigational Site Number 840015 River Forest Illinois 60305 —
Investigational Site Number 840089 Iowa City Iowa 52242 —
Investigational Site Number 840032 Fort Mitchell Kentucky 41017 —
Investigational Site Number 840009 Owensboro Kentucky 42303 —
Investigational Site Number 840064 Bangor Maine 04401 —
Investigational Site Number 840080 Baltimore Maryland 21237 —
Investigational Site Number 840017 Chevy Chase Maryland 20815 —
Investigational Site Number 840073 Gaithersburg Maryland 20878 —
Investigational Site Number 840127 White Marsh Maryland 21162 —
Investigational Site Number 840014 North Dartmouth Massachusetts 02747 —
Investigational Site Number 840005 Minneapolis Minnesota 55402 —
Investigational Site Number 840013 Kansas City Missouri 64111 —
Investigational Site Number 840002 St Louis Missouri 63141 —
Investigational Site Number 840093 St Louis Missouri 63141 —
Investigational Site Number 840026 Missoula Montana 59808 —
Investigational Site Number 840078 Omaha Nebraska 68131 —
Investigational Site Number 840003 Papillion Nebraska 27103 —
Investigational Site Number 840111 Brick New Jersey 08723 —
Investigational Site Number 840068 Ocean City New Jersey 07712 —
Investigational Site Number 840016 Princeton New Jersey 08540 —
Investigational Site Number 840096 Toms River New Jersey 08775 —
Investigational Site Number 840106 Jamaica New York 11435 —
Investigational Site Number 840065 New York New York 10029 —
Investigational Site Number 840076 Rochester New York 14642 —
Investigational Site Number 840031 The Bronx New York 10457 —
Investigational Site Number 840126 Charlotte North Carolina 28226 —
Investigational Site Number 840083 Charlotte North Carolina 28277 —
Investigational Site Number 840108 Durham North Carolina 27705 —
Investigational Site Number 840107 Greensboro North Carolina 27403 —
Investigational Site Number 840007 High Point North Carolina 27262 —
Investigational Site Number 840046 Cincinnati Ohio 45241 —
Investigational Site Number 840049 Middleburg Heights Ohio 44130 —
Investigational Site Number 840042 Toledo Ohio 43617 —
Investigational Site Number 840112 Edmond Oklahoma 73034 —
Investigational Site Number 840121 Oklahoma City Oklahoma 73103 —
Investigational Site Number 840104 Tulsa Oklahoma 74136 —
Investigational Site Number 840040 Clackamas Oregon 97015 —
Investigational Site Number 840039 Medford Oregon 97504 —
Investigational Site Number 840001 Portland Oregon 97223 —
Investigational Site Number 840085 Hershey Pennsylvania 17033 —
Investigational Site Number 840081 Philadelphia Pennsylvania 19102 —
Investigational Site Number 840010 Philadelphia Pennsylvania 19107 —
Investigational Site Number 840067 Philadelphia Pennsylvania 19140 —
Investigational Site Number 840028 Pittsburgh Pennsylvania 15213 —
Investigational Site Number 840091 Pittsburgh Pennsylvania 15241 —
Investigational Site Number 840029 Lincoln Rhode Island 02286 —
Investigational Site Number 840082 Charleston South Carolina 29407 —
Investigational Site Number 840117 Greenville South Carolina 29607 —
Investigational Site Number 840100 Greer South Carolina 29651 —
Investigational Site Number 840054 Spartanburg South Carolina 29303 —
Investigational Site Number 840062 Amarillo Texas 79106 —
Investigational Site Number 840098 Austin Texas 78759 —
Investigational Site Number 840038 Boerne Texas 78006 —
Investigational Site Number 840124 Cypress Texas 77429 —
Investigational Site Number 840008 Dallas Texas 75231 —
Investigational Site Number 840094 Dallas Texas 75246 —
Investigational Site Number 840023 El Paso Texas 79903 —
Investigational Site Number 840022 Fort Worth Texas 76109 —
Investigational Site Number 840027 Fort Worth Texas 76244 —
Investigational Site Number 840066 Killeen Texas 76542 —
Investigational Site Number 840050 Live Oak Texas 78233 —
Investigational Site Number 840070 McKinney Texas 75069 —
Investigational Site Number 840128 McKinney Texas 75071 —
Investigational Site Number 840118 Plano Texas 75093 —
Investigational Site Number 840012 San Antonio Texas 78229 —
Investigational Site Number 840129 San Antonio Texas 78251 —
Investigational Site Number 840133 Sealy Texas 77474 —
Investigational Site Number 840119 Spring Texas 77380 —
Investigational Site Number 840035 Draper Utah 84020 —
Investigational Site Number 840077 Murray Utah 84107 —
Investigational Site Number 840057 South Burlington Vermont 05403 —
Investigational Site Number 840059 Fairfax Virginia 22030 —
Investigational Site Number 840113 Richmond Virginia 23294 —
Investigational Site Number 840051 Bellevue Washington 98225 —
Investigational Site Number 840043 Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 273 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02414854, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 23, 2018 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02414854 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →